Amorepacific Estra Introduces 'Atobarrier Itching Cream MD'

[Asia Economy Reporter Moon Hyewon] Amorepacific's Estra announced on the 14th the launch of the 'Atobarrier Itching Cream MD.'

The new product is a wound dressing medical device used to protect damaged skin barriers and dry skin accompanied by itching. It is an adhesive transparent wound dressing that forms a physical barrier on the skin to maintain moisture, reduce dryness, and prevent secondary skin damage caused by scratching.

It is the first to apply Amorepacific's independently developed patented ingredient 'Asivatrep (PAC-14028).' This ingredient has proven its efficacy and safety through various clinical trial papers and recently attracted significant attention when presented at the 19th Bu-Ul-Gyeong Dermatology Association Academic Conference.

With a highly moisturizing cream formulation, it keeps the skin hydrated while finishing smoothly without stickiness to avoid irritating itchy skin. It is a low-irritant product suitable for use not only on the face but also on all areas requiring skin protection.

It has obtained medical device manufacturing certification from the Korea Medical Device Safety Information Center and is available at over 4,000 hospitals and clinics nationwide, including major general hospitals.

This content was produced with the assistance of AI translation services.